Regulation of newly identified lysine lactylation in cancer

Xin Gao,Chaoyu Pang,Zhiyao Fan,Yunshan Wang,Yangmiao Duan,Hanxiang Zhan
DOI: https://doi.org/10.1016/j.canlet.2024.216680
IF: 9.756
2024-04-01
Cancer Letters
Abstract:Metabolic reprogramming is a typical hallmark of cancer. Enhanced glycolysis in tumor cells leads to the accumulation of lactate, which is traditionally considered metabolic waste. With the development of high-resolution liquid chromatography coupled with tandem mass spectrometry (LC-MS/MS), the lactate-derived, lysine lactylation(Kla), has been identified. Kla can alter the spatial configuration of chromatin and regulate the expression of corresponding genes. Metabolic reprogramming and epigenetic remodeling have been extensively linked. Accumulating studies have subsequently expanded the framework on the key roles of this protein translational modification (PTM) in tumors and have provided a new concept of cancer-specific regulation by Kla.
oncology
What problem does this paper attempt to address?